Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Byrne

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Schizophrenia (Heidelberg, Germany)|February 26, 2025
Clinical prediction model for transition to psychosis in individuals meeting At Risk Mental State criteriaLaura J Bonnett, Alexandra Hunt, Allan Flores, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 13, 2013
Impact of cognitive therapy on internalised stigma in people with at-risk mental statesAnthony P Morrison, Max Birchwood, Melissa Pyle, et al.
Health Technology Assessment (Winchester, England)|November 29, 2021
Social recovery therapy for young people with emerging severe mental illness: the Prodigy RCTDavid Fowler, Clio Berry, Joanne Hodgekins, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 26, 2022
Clinical and cost-effectiveness of social recovery therapy for the prevention and treatment of long-term social disability among young people with emerging severe mental illness (PRODIGY): randomised controlled trialClio Berry, Joanne Hodgekins, Paul French, et al.
Trials|July 12, 2017
Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness with social recovery therapy (The PRODIGY Trial): study protocol for a randomised controlled trialDavid Fowler, Paul French, Robin Banerjee, et al.
Early Intervention in Psychiatry|January 29, 2011
Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristicsAnthony P Morrison, Suzanne L K Stewart, Paul French, et al.
Psychological Medicine|December 27, 2024
A feasibility randomized controlled trial of an individually delivered, peer support intervention to reduce the impact of psychosis stigma and discrimination for people with psychosis: the let's talk studyMelissa Pyle, Patrick W Corrigan, Lisa Wood, et al.
The Lancet. Psychiatry|July 14, 2018
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trialAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.
BMC Psychiatry|August 7, 2016
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trialMelissa Pyle, John Norrie, Matthias Schwannauer, et al.
Lancet (London, England)|February 11, 2014
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trialAnthony P Morrison, Douglas Turkington, Melissa Pyle, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Schizophrenia (Heidelberg, Germany)|February 26, 2025
Clinical prediction model for transition to psychosis in individuals meeting At Risk Mental State criteriaLaura J Bonnett, Alexandra Hunt, Allan Flores, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 13, 2013
Impact of cognitive therapy on internalised stigma in people with at-risk mental statesAnthony P Morrison, Max Birchwood, Melissa Pyle, et al.
Health Technology Assessment (Winchester, England)|November 29, 2021
Social recovery therapy for young people with emerging severe mental illness: the Prodigy RCTDavid Fowler, Clio Berry, Joanne Hodgekins, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 26, 2022
Clinical and cost-effectiveness of social recovery therapy for the prevention and treatment of long-term social disability among young people with emerging severe mental illness (PRODIGY): randomised controlled trialClio Berry, Joanne Hodgekins, Paul French, et al.
Trials|July 12, 2017
Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness with social recovery therapy (The PRODIGY Trial): study protocol for a randomised controlled trialDavid Fowler, Paul French, Robin Banerjee, et al.
Early Intervention in Psychiatry|January 29, 2011
Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristicsAnthony P Morrison, Suzanne L K Stewart, Paul French, et al.
Psychological Medicine|December 27, 2024
A feasibility randomized controlled trial of an individually delivered, peer support intervention to reduce the impact of psychosis stigma and discrimination for people with psychosis: the let's talk studyMelissa Pyle, Patrick W Corrigan, Lisa Wood, et al.
The Lancet. Psychiatry|July 14, 2018
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trialAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.
BMC Psychiatry|August 7, 2016
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trialMelissa Pyle, John Norrie, Matthias Schwannauer, et al.
Lancet (London, England)|February 11, 2014
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trialAnthony P Morrison, Douglas Turkington, Melissa Pyle, et al.
Pageof 4